JP2007508270A - I.a.ジスリピデミアの治療におけるhppar作用物質として使用するためのチアゾール−2−カルボキシアミド誘導体 - Google Patents
I.a.ジスリピデミアの治療におけるhppar作用物質として使用するためのチアゾール−2−カルボキシアミド誘導体 Download PDFInfo
- Publication number
- JP2007508270A JP2007508270A JP2006530145A JP2006530145A JP2007508270A JP 2007508270 A JP2007508270 A JP 2007508270A JP 2006530145 A JP2006530145 A JP 2006530145A JP 2006530145 A JP2006530145 A JP 2006530145A JP 2007508270 A JP2007508270 A JP 2007508270A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- hppar
- compounds
- ppar
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0323702.1A GB0323702D0 (en) | 2003-10-09 | 2003-10-09 | Chemical compound |
| PCT/EP2004/011386 WO2005037804A1 (en) | 2003-10-09 | 2004-10-07 | Thiazole-2-carboxamide derivatives for use as hppar agonists in the treatment of i.a. dyslipidemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007508270A true JP2007508270A (ja) | 2007-04-05 |
| JP2007508270A5 JP2007508270A5 (cg-RX-API-DMAC7.html) | 2007-06-28 |
Family
ID=29433611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006530145A Pending JP2007508270A (ja) | 2003-10-09 | 2004-10-07 | I.a.ジスリピデミアの治療におけるhppar作用物質として使用するためのチアゾール−2−カルボキシアミド誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070167628A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1680410A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007508270A (cg-RX-API-DMAC7.html) |
| AR (1) | AR046058A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0323702D0 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200518748A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005037804A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011163198A2 (en) * | 2010-06-21 | 2011-12-29 | Board Of Regents, The University Of Texas System | Tg2 inhibitors and uses thereof |
| CN108486209B (zh) * | 2018-03-22 | 2022-03-18 | 浙江工业大学 | 一种高通量快速筛选产(r)-2-(4-羟基苯氧基)丙酸菌株的方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999046232A1 (en) * | 1998-03-10 | 1999-09-16 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| WO2002096895A1 (en) * | 2001-05-31 | 2002-12-05 | Glaxo Group Limited | Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor |
-
2003
- 2003-10-09 GB GBGB0323702.1A patent/GB0323702D0/en not_active Ceased
-
2004
- 2004-10-07 EP EP04790285A patent/EP1680410A1/en not_active Withdrawn
- 2004-10-07 AR ARP040103636A patent/AR046058A1/es not_active Application Discontinuation
- 2004-10-07 WO PCT/EP2004/011386 patent/WO2005037804A1/en not_active Ceased
- 2004-10-07 TW TW093130422A patent/TW200518748A/zh unknown
- 2004-10-07 US US10/575,530 patent/US20070167628A1/en not_active Abandoned
- 2004-10-07 JP JP2006530145A patent/JP2007508270A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999046232A1 (en) * | 1998-03-10 | 1999-09-16 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| WO2002096895A1 (en) * | 2001-05-31 | 2002-12-05 | Glaxo Group Limited | Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor |
Also Published As
| Publication number | Publication date |
|---|---|
| US20070167628A1 (en) | 2007-07-19 |
| WO2005037804A1 (en) | 2005-04-28 |
| EP1680410A1 (en) | 2006-07-19 |
| GB0323702D0 (en) | 2003-11-12 |
| TW200518748A (en) | 2005-06-16 |
| AR046058A1 (es) | 2005-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3884290B2 (ja) | Hpparアルファアクチベーターとしての置換オキサゾールおよびチアゾール誘導体 | |
| EP1392665B1 (en) | Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases | |
| AU2002312954A1 (en) | Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases | |
| JP2004517100A (ja) | hPPARアルファアゴニストとしての置換オキサゾールおよびチアゾール | |
| EP1399430B1 (en) | Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor | |
| AU2002317765A1 (en) | Oxazol/ thiazol-derivatives activators of the hPPAR-alpha receptor | |
| US7141591B2 (en) | 1,2,4-oxadiazole derivatives as hPPAR alpha agonists | |
| AU2002220902A1 (en) | 1, 2, 4-oxadiazole derivatives as hPPAR alpha agonists | |
| US20070167628A1 (en) | Thiazole-2-carboxamide derivatives for use as hippar agonists in the treatment of i.a. dyslipidemia | |
| HK1064367B (en) | Oxazol/thiazol-derivatives activators of the hppar-alpha receptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070511 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070511 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101102 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110329 |